Target intelligence / Profile preview

Ubiquitin conjugating enzyme E2 V1 pseudogene 7 (UBE2V1P7)

Target
UBE2V1P7
Molecular classification
Other (Pseudogene)
01

Overview

UBE2V1 pseudogene 7 (UBE2V1P7) is a non-protein-coding pseudogene. While the related UBE2V1 gene encodes a variant E2 ubiquitin-conjugating enzyme involved in cell cycle regulation, DNA repair, and signaling, UBE2V1P7 itself has no demonstrated protein product, functional role, or disease association. It should not be considered a therapeutic target or receptor. The designation "pseudogene" indicates it represents a non-functional copy or fragment related to the functional UBE2V1 gene[5]. UBE2V1P7 is explicitly labeled as a pseudogene in genetic databases and does not encode an active protein product nor act as a known molecular target[5]. All functional information—including enzymatic activity, involvement in cell cycle, signaling, DNA repair—applies to the *functional* UBE2V1 gene, **not** to UBE2V1P7[1][3][4]. No biological function, drug interactions, or disease associations are reported or expected for UBE2V1P7[5]. There is no evidence it serves as a biomarker or presents safety concerns in therapeutic contexts.

Other names
UBE2V1P7Ubiquitin conjugating enzyme E2 variant 1 pseudogene 7Ubiquitin conjugating enzyme E2 V1 pseudogene 7

Beyond the preview

Go deeper on Ubiquitin conjugating enzyme E2 V1 pseudogene 7 (UBE2V1P7).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ubiquitin conjugating enzyme E2 V1 pseudogene 7 (UBE2V1P7).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call